Hemophilia Drugs Market 2019 Analysis, Exhibit 6.0% CAGR and Remarkable Growth Rate forecast till 2025

Hemophilia Drugs Market is projected for better diagnosis because patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process, Hemophilia Drugs Industry exhibit a 6.0% & strong growth in the coming years

pune, india - May 16, 2019 /MarketersMedia/ —

The Global Hemophilia Drugs Market covered a value of US$ 9875.4 Mn in the year 2017 and is anticipated to reach US$ 15830.3 Mn by 2025. Furthermore, the global market for hemodialysis is expected to report a CAGR of 6.0% during the forecast period. The above information was published in a report, titled “Hemophilia Drugs Market Size, Share and Global Trend by Disease Indication (Hemophilia A, B & C), Therapy Type (Recombinant Therapy, Plasma therapy & Others), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2025.”

The rising prevalence of severe diseases is one of the major concerns in the healthcare industry. Among these disorders, patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process. Companies are introducing novel hemophilia drugs and therapies to fulfil the unmet needs of patients and maintain their quality of life. A lead analyst at Fortune Business Insights said, “Companies are building expansion strategies to develop new hemophilia drugs so as to offer better diagnosis.”

Among disease indications, hemophilia A is projected to exhibit a strong growth in the coming years. In addition to this, this segment covered a share of 85% in the global hemophilia drugs market in 2017. This is mainly attributable to the rising pool patients suffering from hemophilia across the world. Also, rising initiatives at developing and commercializing new products for the effective treatment of hemophilia is driving this segment’s growth. Following hemophilia A, hemophilia B drugs are also expected to grow at a considerable rate in the years to come.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/hemophilia-drugs-market-100068

Asia Pacific to Grow at a Rapid Pace with Rising Number of Hemophilia Patients

North America is projected to emerge dominant in the global hemophilia drugs market during the forecast period. This is mainly ascribable to the rising prevalence of hemophilia A and B, especially in countries such as Canada and the U.S. Moreover, in 2017, North America market for hemophilia drugs covered a value of US$ 3,684.7 Mn. Trailing North America, Europe is the second-leading region in the global hemophilia drugs market. The growth in this region is attributable to the rising healthcare budgets by governments and initiatives by governments to promote hemophilia drugs treatment. On the other hand, the hemophilia drugs market in Asia Pacific is likely to expand at a higher CAGR between 2017 and 2025 on account of rising number of patients suffering from hemophilia especially in countries such as China and India.

Rising Awareness About Hemophilia to Augment the Demand

The primary factor augmenting the hemophilia drugs market is the recent developments in hemophilia treatment. A lead analyst at Fortune Business Insights said “Several new drugs are expected to enter the global market in the coming years.” Also, hemophilia surgical management is gaining traction on account of increasing awareness about hemophilia across the world. Moreover, governments are planning to conduct awareness initiatives to spread knowledge regarding the use of hemophilia treatment and drugs This, in turn, is expected to drive the hemophilia drugs market over the next few years. The genetic evolution is leading to rising incidences of bleeding disorders across the world. This will further lead to hemophilia drug development in the next few years to come. As per the study conducted by the National Hemophilia Foundation or NHF in 2015, about 1% of the U.S. population is likely to suffer from a disease called von Willebrand, hence rising the need for hemophilia treatment drugs.

Pfizer Introduced Gene Therapy to Address Unmet Patient’s Needs

Some of the leading players presently operating in the global market for hemophilia drugs are Grifols SA, Bioverativ Inc., FERRING LÄKEMEDEL AB, Aptevo Therapeutics, Hoffmann-La Roche Ltd, Novo Nordisk, Pfizer, Inc. and CSL Behring. In 2018, companies such as Novo Nordisk, Takeda Pharmaceutical Company Ltd., and F. Hoffmann-La Roche Ltd covered more than half of the share in the global hemodialysis market as per revenue. In 2017, Pfizer, Inc. collaborated with Sangamo Therapeutics, Inc. to commercialize and develop gene therapy programs. The aim was to utilize these programs for Hemophilia A drugs.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/hemophilia-drugs-market-100068

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: 1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/hemophilia-drugs-market-2019-analysis-exhibit-60-cagr-and-remarkable-growth-rate-forecast-till-2025/513243

Source: MarketersMedia

Release ID: 513243

More News From Enter Hollywood

North, South Korean musicians hold rare joint performance

May 26, 2019

SHANGHAI — South Korean violinist Won Hyung Joon took the stage, nodded once to his North Korean soprano partner, and placed his instrument on his shoulder. With a flick of the conductor's wrist, she began to sing, and he began to bow — the beginning of a rare joint performance Sunday that they hope will bring the Koreas closer amid deadlocked nuclear diplomacy. "Until today, I was thinking, will this really happen? Will it suddenly be canceled?" Won said. "Today was the day my dream finally came true." Won, donning a white shirt, and Kim Song Mi, sporting a sparkling...

Michael Wolf, photographer of mega-cities, dies in Hong Kong

May 26, 2019

HONG KONG — Michael Wolf, an award-winning photographer known for his work depicting megacities, has died at his home in Hong Kong. He was 64. Wolf died in his sleep on Wednesday, said Sarah Greene, an art gallery director who worked closely with him. She did not give a cause of death. Wolf won first prize in the World Press Photo competition twice, for contemporary issues in 2005 and for daily life in 2010. His body of work included Tokyo, Chicago, Paris and Hong Kong, where Wolf moved in 1994. "His main muse was Hong Kong," said Greene, the director...

Artisan keeps his craft alive with each carved mahjong tile

May 26, 2019

HONG KONG — Just opposite the entrance to a neon-lit night market, one of Hong Kong's few remaining carvers of mahjong tiles engraves the two Chinese characters for the number 8,000 on a piece of acrylic. With a knife in his right hand, Cheung Shun-king turns the tile with the other to cut into it. From time to time, he gently blows away the shavings. His is a dying craft in an era of mass-produced tiles for the table-top game, popular in southern China, Hong Kong and Taiwan. The 65-year-old artisan believes there are only three or four carvers left...

Fed Cup semi: Australia, Belarus tied 2-2 ahead of doubles

May 26, 2019

BRISBANE, Australia — The Fed Cup semifinal between Australia and Belarus is going to a doubles decider. Victoria Azarenka beat Australia's Sam Stosur in the second reverse singles Sunday 6-1, 6-1 in 59 minutes to even the match at 2-2 on hard courts at Pat Rafter Arena. In the second set, Azarenka went ahead 3-1 when Stosur double-faulted to set up break point. Azarenka's win was met with loud cheers from the small but noisy group of Belarusian fans waving their country's red and green flag. In the deciding doubles, Ashleigh Barty and Stosur were expected to play Vera Lapko...

Fed Cup semifinal: Australia, Belarus level after 1st day

May 26, 2019

BRISBANE, Australia — Australian Ashleigh Barty beat doubles partner Victoria Azarenka of Belarus 7-6 (2), 6-3 to level their Fed Cup semifinal at 1-1 on Saturday. Barty's win on hard courts at Pat Rafter Arena ended Azarenka's 13-match winning streak in the Fed Cup. "I knew the first set would be key," Barty said after the opening day of singles. "It was just about me coming out and doing everything right. I prepared really well all week. This is why we train, we want to get down to crunch time, go out and enjoy it." Earlier, Aryna Sabalenka gave Belarus...

Sign up now!